Listed

Eastman Chemical Co: Form 10-Q for the period ended Mar 31, 2025

Filed with the SEC on Apr 25, 2025 and accepted by EDGAR at Apr 25, 2025, 12:25 ET.

Share

Management's discussion and analysis

As filed, 36,162 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Page

Non-GAAP Financial Measures 28
Overview 30
Results of Operations 31
Summary by Operating Segment 34
Sales by Customer Location 36
Liquidity and Other Financial Information 37
Critical Accounting Estimates 39
Recently Issued Accounting Standards 39

This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is based upon the unaudited consolidated financial statements of Eastman Chemical Company ("Eastman" or the "Company"), which have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP"), and should be read in conjunction with the Company's audited consolidated financial statements, including related notes, and MD&A contained in the Company's 2024 Annual Report on Form 10-K, and the unaudited consolidated financial statements, including related notes, included in Part I, Item 1, in this Quarterly Report. All references to earnings per share ("EPS") contained in this report are diluted EPS unless otherwise noted.

NON-GAAP FINANCIAL MEASURES

Non-GAAP financial measures, and the accompanying reconciliations of the non-GAAP financial measures to the most comparable GAAP measures, are presented below in this section and in "Overview", "Results of Operations", "Summary by Operating Segment", and "Liquidity and Other Financial Information - Cash Flows" in this MD&A.

Management discloses non-GAAP financial measures, and the related reconciliations to the most comparable GAAP financial measures, because it believes investors use these metrics in evaluating longer term period-over-period performance, and to allow investors to better understand and evaluate the information used by management to assess the Company's and its operating segments' performances, make resource allocation decisions, and evaluate organizational and individual performances in determining certain performance-based compensation. Non-GAAP financial measures do not have definitions under GAAP, and may be defined differently by, and not be comparable to, similarly titled measures used by other companies. As a result, management cautions investors not to place undue reliance on any non-GAAP financial measure, but to consider such measures alongside the most directly comparable GAAP financial measure.

Company Use of Non-GAAP Financial Measures

Non-Core Items and any Unusual or Non-Recurring Items Excluded from Non-GAAP Earnings

In addition to evaluating Eastman's financial condition, results of operations, liquidity, and cash flows as reported in accordance with GAAP, management evaluates Company and operating segment performance, and makes resource allocation and performance evaluation decisions, excluding the effect of transactions, costs, and losses or gains that do not directly result from Eastman's normal, or "core", business and operations, or are otherwise of an unusual or non-recurring nature.

  • Non-core transactions, costs, and losses or gains relate to, among other things, cost reductions, growth and profitability improvement initiatives, changes in businesses and assets, and other events outside of the Company's core business operations, and have included asset impairments, restructuring, and other charges and gains, costs of and related to acquisitions, gains and losses from and costs related to dispositions, closures, or shutdowns of businesses or assets, financing transaction costs, environmental and other costs related to previously divested businesses or non-operational sites and product lines, and mark-to-market losses or gains for pension and other postretirement benefit plans.

Because non-core, unusual, or non-recurring transactions, costs, and losses or gains may materially affect the Company's, or any particular operating segment's, financial condition or results in a specific period in which they are recognized, management believes it is appropriate to evaluate the financial measures prepared and calculated in accordance with both GAAP and the related non-GAAP financial measures excluding the effect on the Company's results of these non-core, unusual, or non-recurring items. In addition to using such measures to evaluate results in a specific period, management evaluates such non-GAAP measures, and believes that investors may also evaluate such measures, because such measures may provide more complete and consistent comparisons of the Company's, and its segments', operational performance on a period-over-period historical basis and, as a result, provide a better indication of expected future trends.

Adjusted Tax Rate and Provision for Income Taxes

In interim periods, Eastman discloses non-GAAP earnings with an adjusted effective tax rate and a resulting adjusted provision for income taxes using the Company's forecasted tax rate for the full year as of the end of the interim period. The adjusted effective tax rate and resulting adjusted provision for income taxes are equal to the Company's projected full year effective tax rate and provision for income taxes on earnings excluding non-core, unusual, or non-recurring items for completed periods. The adjusted effective tax rate and resulting adjusted provision for income taxes may fluctuate during the year for changes in events and circumstances that change the Company's forecasted annual effective tax rate and resulting provision for income taxes excluding non-core, unusual, or non-recurring items. Management discloses this adjusted effective tax rate, and the related reconciliation to the GAAP effective tax rate, to provide investors more complete and consistent comparisons of the Company's operational performance on a period-over-period interim basis and on the same basis as management evaluates quarterly financial results to provide a better indication of expected full year results.

Non-GAAP Debt Measure

Eastman, from time to time, evaluates and discloses to investors and securities and credit analysts the non-GAAP debt measure "net debt", which management defines as total borrowings less cash and cash equivalents. Management believes this metric is useful to investors and securities and credit analysts to provide them with information similar to that used by management in evaluating the Company's overall financial position, liquidity, and leverage and because management believes investors, securities analysts, credit analysts and rating agencies, and lenders often use a similar measure to assess and compare companies' relative financial position and liquidity.

Non-GAAP Measures in this Quarterly Report

The following non-core items are excluded by management in its evaluation of certain earnings results in this Quarterly Report:

  • Asset impairments, restructuring, and other charges, net.

As described above, the alternative non-GAAP measure of debt, "net debt", is also presented in this Quarterly Report.

Non-GAAP Financial Measures - Non-Core Items Excluded from Earnings and Adjustments to Provision for Income Taxes

(Dollars in millions)

Non-core items impacting earnings before interest and taxes: First Quarter 2025 2024
Asset impairments, restructuring, and other charges, net $9 $11
Total non-core items impacting earnings before interest and taxes 9 11
Less: Items impacting provision for income taxes:
Tax effect of non-core items 1 3
Interim adjustment to tax provision (32) (17)
Total items impacting provision for income taxes (31) (14)
Total items impacting net earnings attributable to Eastman $40 $25

This MD&A includes an analysis of the effect of the foregoing on the following GAAP financial measures:

  • Earnings before interest and taxes ("EBIT");
  • Provision for income taxes;
  • Net earnings attributable to Eastman;
  • Diluted EPS; and
  • Total borrowings.

OVERVIEW

Eastman's products and operations are managed and reported in four operating segments: Advanced Materials ("AM"), Additives & Functional Products ("AFP"), Chemical Intermediates ("CI"), and Fibers. Eastman uses an innovation-driven growth model which consists of leveraging world class scalable technology platforms, delivering differentiated application development capabilities, and relentlessly engaging the market. The Company's world class technology platforms, scale advantage, and sustainability macrotrends form the foundation of the Company's research and development ("R&D") and innovation initiatives. Molecular recycling technologies continue to be an area of investment focus for the Company and extends the level of differentiation afforded by our world class technology platforms. Eastman began operating one of the world's largest molecular recycling facilities in 2024. Differentiated application development converts market complexity into opportunities for growth and accelerates innovation by enabling a deeper understanding of the value of Eastman's products and how they perform within customers' and end-user products. Key areas of application development include thermoplastic conversion, functional films, coatings formulations, textiles, and personal and home care formulations. The Company engages the market by working directly with customers and downstream users, targeting attractive niche markets, and leveraging disruptive macro trends. Management believes that these elements of the Company's innovation-driven growth model, combined with disciplined portfolio management and balanced capital deployment, will result in consistent, sustainable earnings growth and strong cash flow from operations.

Sales, EBIT, and EBIT excluding non-core items were as follows:

(Dollars in millions)

First Quarter 2025 2024
Sales $2,290 $2,310
Earnings before interest and taxes 302 263
Earnings before interest and taxes excluding non-core items 311 274

Sales revenue decreased in first quarter 2025 compared to first quarter 2024 as lower sales volume and an unfavorable shift in foreign currency exchange rates were partially offset by higher selling prices.

EBIT excluding non-core items increased in first quarter 2025 compared to first quarter 2024 primarily due to the absence of start-up costs at the Kingsport methanolysis facility, as well as higher selling prices and lower distribution costs, net of higher raw material and energy costs. These net positive impacts were partially offset by lower sales volume in the Fibers segment and an unfavorable shift in foreign currency exchange rates.

Further discussion of sales revenue and EBIT changes is presented in "Results of Operations" and "Summary by Operating Segment" in this MD&A.

Net earnings and EPS and adjusted net earnings and EPS were as follows:

(Dollars in millions, except EPS)

First Quarter 2025 $EPS 2024 $EPS
Net earnings attributable to Eastman $182 $1.57 $165 $1.39
Total non-core items, net of tax 8 0.06 8 0.07
Interim adjustment to tax provision 32 0.28 17 0.15
Adjusted net earnings $222 $1.91 $190 $1.61

Cash used in operating activities was $167 million in first three months 2025 and $16 million in first three months 2024.

RESULTS OF OPERATIONS

Sales

(Dollars in millions)

First Quarter 2025 2024 Change $%
Sales $2,290 $2,310 $(20) (1)%
Volume / product mix effect (23) (1)%
Price effect 27 1%
Exchange rate effect (24) (1)%

Sales revenue decreased in first quarter 2025 compared to first quarter 2024 primarily as a result of decreases in the Fibers and AM segments partially offset by increases in the AFP and CI segments. Further discussion by operating segment is presented in "Summary by Operating Segment" in this MD&A.

Gross Profit

(Dollars in millions)

First Quarter 2025 2024 Change
Gross profit $567 $532 7%

Gross profit increased in first quarter 2025 compared to first quarter 2024 due to increases in all segments except Fibers. Further discussion of sales revenue and EBIT changes is presented in "Summary by Operating Segment" in this MD&A.

Selling, General and Administrative Expenses

(Dollars in millions)

First Quarter 2025 2024 Change
Selling, general and administrative expenses $182 $191 (5)%

Selling, general and administrative ("SG&A") expenses decreased in first quarter 2025 compared to first quarter 2024 primarily due to lower deferred compensation expenses.

Research and Development Expenses

(Dollars in millions)

First Quarter 2025 2024 Change
Research and development expenses $67 $59 14%

R&D expenses increased in first quarter 2025 compared to first quarter 2024 primarily due to strategic investment in innovation.

Asset Impairments, Restructuring, and Other Charges, Net

(Dollars in millions)

First Quarter 2025 2024
Severance charges $1 $11
Restructuring and other charges 8 —
Total $9 $11

31

For detailed information regarding asset impairments, restructuring, and other charges, net see Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

Other Components of Post-employment (Benefit) Cost, Net

(Dollars in millions)

First Quarter 2025 2024
Other components of post-employment (benefit) cost, net $(1) $(5)

For more information regarding other components of post-employment (benefit) cost, net see Note 6, "Retirement Plans", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

Other (Income) Charges, Net

(Dollars in millions)

First Quarter 2025 2024
Foreign exchange transaction losses, net $— $5
(Income) loss from equity investments and other investment (gains) losses, net 1 —
Other, net 7 8
Other (income) charges, net $8 $13

Other (income) charges, net decreased in first quarter 2025 compared to first quarter 2024 primarily due to the absence of losses on foreign exchange transactions in first quarter 2025. For more information regarding components of foreign exchange transaction losses, see Note 5, "Derivative and Non-Derivative Financial Instruments", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

Earnings Before Interest and Taxes

(Dollars in millions)

First Quarter 2025 2024 Change
Earnings before interest and taxes $302 $263 15%
Asset impairments, restructuring, and other charges, net 9 11
Earnings before interest and taxes excluding non-core items $311 $274 14%

Net Interest Expense

(Dollars in millions)

First Quarter 2025 2024 Change
Gross interest costs $58 $58 —%
Less: Capitalized interest 5 5
Interest expense 53 53
Less: Interest income 4 4
Net interest expense $49 $49 —%

Net interest expense remained unchanged in first quarter 2025 compared to first quarter 2024.

Provision for Income Taxes

(Dollars in millions)

First Quarter 2025 $% 2024 $%
Provision for income taxes and effective tax rate $70 28% $49 23%
Tax provision for non-core items (1) 1 3
Interim adjustment to tax provision (2) (32) (17)
Adjusted provision for income taxes and effective tax rate $39 16% $35 16%

(1) Provision for income taxes for non-core items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.

(2) First quarter 2025 provision for income taxes was adjusted to reflect the current forecasted full year effective tax rate. First quarter 2024 provision for income taxes was adjusted to reflect the then current forecasted full year effective tax rate.

First Three Months (1) 2025 2024
Effective tax rate 28% 23%
Discrete tax items (2) (2)% (1)%
Tax impact of current year non-core items (3) 1% 1%
Changes in tax contingencies and valuation allowances (2)% (1)%
Forecasted full year impact of expected tax events (4) (9)% (6)%
Forecasted full year adjusted effective tax rate 16% 16%

(1) Effective tax rate percentages are rounded to the nearest whole percent. The forecasted full year effective tax rates are 15.5 percent in both first three months 2025 and 2024, respectively.

(2) "Discrete tax items" are items that are excluded from the Company's estimated annual effective tax rate and recognized entirely in the quarter in which the item occurs. Discrete tax items for first three months 2025 are related to share based compensation expense and adjustments to certain prior year tax returns and first three months 2024 are related to share based compensation expense.

(3) Provision for income taxes for non-core items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.

(4) Expected future tax events may include finalization of tax returns; federal, state, and foreign examinations or the expiration of statutes of limitation; and corporate restructurings.

Net Earnings Attributable to Eastman and Diluted Earnings per Share

(Dollars in millions, except EPS)

First Quarter 2025 $EPS 2024 $EPS
Net earnings and diluted earnings per share attributable to Eastman $182 $1.57 $165 $1.39
Non-core items, net of tax: (1)
Asset impairments, restructuring, and other charges, net 8 0.06 8 0.07
Interim adjustment to tax provision 32 0.28 17 0.15
Adjusted net earnings and diluted earnings per share attributable to Eastman $222 $1.91 $190 $1.61

(1) Provision for income taxes for non-core items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.

SUMMARY BY OPERATING SEGMENT

Eastman's products and operations are managed and reported in four operating segments: Advanced Materials ("AM"), Additives & Functional Products ("AFP"), Chemical Intermediates ("CI"), and Fibers. For additional financial and product information for each operating segment, see Part I, Item 1, "Business - Business Segments" and Part II, Item 8, Note 20, "Segment and Regional Sales Information", in the Company's 2024 Annual Report on Form 10-K.

Advanced Materials Segment

(Dollars in millions)

First Quarter 2025 2024 Change $%
Sales $719 $748 $(29) (4)%
Volume / product mix effect (7) (1)%
Price effect (13) (2)%
Exchange rate effect (9) (1)%
Earnings before interest and taxes $116 $104 $12 12%

Sales revenue decreased in first quarter 2025 compared to first quarter 2024 primarily due to lower selling prices across the segment. Lower sales volume was driven by weakened demand in the automotive and building and construction end-markets, partially offset by growth in the specialty plastics product line.

EBIT increased in first quarter 2025 compared to first quarter 2024 primarily due to $7 million favorable sales volume mix and $8 million lower SG&A expenses, partially offset by a $5 million unfavorable shift in foreign currency rates.

Additives & Functional Products Segment

(Dollars in millions)

First Quarter 2025 2024 Change $%
Sales $733 $704 $29 4%
Volume / product mix effect 15 2%
Price effect 24 3%
Exchange rate effect (10) (1)%
Earnings before interest and taxes $137 $109 $28 26%
Asset impairments, restructuring, and other charges, net 4 — 4
Earnings before interest and taxes excluding non-core item 141 109 32 29%

Sales revenue increased in first quarter 2025 compared to first quarter 2024 primarily due to higher selling prices, driven by cost pass-through contracts, and higher sales volume, primarily in the coatings additives and specialty fluids product lines.

EBIT in first quarter 2025 included asset impairments, restructuring, and other charges, net of $4 million related to the closure of a heat-transfer fluids production line at a specialty fluids and energy facility in North America. For more information see Note 11, "Asset Impairments, Restructuring, and Other Charges, Net" to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

Excluding this non-core item, EBIT increased in first quarter 2025 compared to first quarter 2024 primarily due to $13 million higher selling prices, net of higher raw material and energy costs, $11 million higher sales volume, and $5 million improved asset utilization.

Chemical Intermediates Segment

(Dollars in millions)

First Quarter 2025 2024 Change $%
Sales $545 $523 $22 4%
Volume / product mix effect 8 2%
Price effect 18 3%
Exchange rate effect (4) (1)%
Earnings before interest and taxes $19 $16 $3 19%

Sales revenue increased in first quarter 2025 compared to first quarter 2024 due to higher selling prices and higher sales volume, partially offset by an unfavorable shift in foreign currency rates. Higher selling prices and higher sales volume were primarily due to more favorable market conditions in some olefins-based products.

EBIT increased in first quarter 2025 compared to first quarter 2024 primarily due to $15 million higher selling prices and lower distribution costs, net of higher raw material and energy costs, partially offset by $8 million unfavorable product mix and $3 million higher manufacturing costs.

Fibers Segment

(Dollars in millions)

First Quarter 2025 2024 Change $%
Sales $288 $331 $(43) (13)%
Volume / product mix effect (40) (12)%
Price effect (2) (1)%
Exchange rate effect (1) —%
Earnings before interest and taxes $88 $117 $(29) (25)%

Sales revenue decreased in first quarter 2025 compared to first quarter 2024 primarily due to lower sales volume attributed to continued customer inventory destocking in the acetate tow product line and the impact of a discontinued product.

EBIT decreased in first quarter 2025 compared to first quarter 2024 primarily due to $25 million lower sales volume.

Other

(Dollars in millions)

First Quarter 2025 2024
Sales $5 $4
Loss before interest and taxes
Growth initiatives and businesses not allocated to operating segments $(51) $(68)
Pension and other postretirement benefits income (expense), net not allocated to operating segments 1 2
Asset impairments, restructuring, and other charges, net (5) (11)
Other income (charges), net not allocated to operating segments (3) (6)
Loss before interest and taxes $(58) $(83)
Asset impairments, restructuring, and other charges, net 5 11
Loss before interest and taxes excluding non-core items (53) (72)

Sales and costs related to growth initiatives, including the cellulosics biopolymer and circular economy platforms, R&D costs, certain components of pension and other postretirement benefits, and other expenses and income not identifiable to an operating segment are included in "Other". First quarter 2024 also included pre-production costs for the Kingsport methanolysis facility.

EBIT in first quarter 2025 included profitability improvement initiatives. First quarter 2024 included severance primarily in accordance with foreign regulatory requirements as a result of cost reduction initiatives in fourth quarter 2023. For more information, see "Non-GAAP Financial Measures" in this MD&A. For more information regarding asset impairments, restructuring, and other charges, net, see Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

SALES BY CUSTOMER LOCATION

(Dollars in millions)

Sales Revenue First Quarter 2025 2024 Change $%
United States and Canada $1,020 $969 $51 5%
Europe, Middle East, and Africa 610 659 (49) (7)%
Asia Pacific 539 564 (25) (4)%
Latin America 121 118 3 3%
Total Eastman $2,290 $2,310 $(20) (1)%

Sales revenue decreased 1 percent in first quarter 2025 compared to first quarter 2024. Lower sales revenue in Europe, Middle East, and Africa was across all segments except the AFP segment, and lower sales revenue in Asia Pacific was primarily in the Fibers segment. Higher sales revenue in United States and Canada was primarily in the CI segment.

Further discussion by operating segment is presented in "Summary by Operating Segment" in this MD&A.

LIQUIDITY AND OTHER FINANCIAL INFORMATION

Cash Flows

Cash flows from operations, cash and cash equivalents, and other sources of liquidity are expected to be available and sufficient to meet known short- and long-term cash requirements. However, the Company's cash flows from operations can be affected by numerous factors, including risks associated with global operations, raw material availability and cost, demand for and pricing of Eastman's products, capacity utilization, and other factors described under "Risk Factors" in Part II, Item 1A of this Quarterly Report. Management believes maintaining a financial profile that supports an investment grade credit rating is important to its long-term strategy and financial flexibility.

(Dollars in millions)

Net cash provided by (used in) First Three Months 2025 2024
Operating activities $(167) $(16)
Investing activities (131) (179)
Financing activities (124) 148
Effect of exchange rate changes on cash and cash equivalents 3 (2)
Net change in cash and cash equivalents (419) (49)
Cash and cash equivalents at beginning of period 837 548
Cash and cash equivalents at end of period $418 $499

Cash used in operating activities increased $151 million in first three months 2025 compared to first three months 2024 primarily due to higher working capital and higher variable compensation payout.

Cash used in investing activities decreased $48 million in first three months 2025 compared to first three months 2024 primarily due to lower capital expenditures and higher government incentives, both primarily for the AM segment methanolysis plastic-to-plastic molecular recycling manufacturing facilities.

Cash used in financing activities was $124 million in first three months 2025 compared to cash provided by financing activities of $148 million first three months 2024 primarily due to lower net borrowings. For additional information, see "Liquidity and Other Financial Information - Debt and Other Commitments" in this MD&A.

Working Capital Management and Off Balance Sheet Arrangements

Eastman applies a proactive and disciplined approach to working capital management to optimize cash flow and to enable a full range of capital allocation options in support of the Company's strategy. Eastman expects to continue utilizing the programs described below to support operating cash flow consistent with past practices.

The Company engages in off-balance sheet, uncommitted accounts receivable factoring programs as a routine part of its ordinary business operations. Through these programs, entire invoices may be sold to third-party financial institutions, the vast majority of which are without recourse. Under these agreements, the Company sells the invoices at face value, less a transaction fee, which substantially equals the carrying value and fair value with no gain or loss recognized, and no credit loss exposure is retained. Available capacity under these programs, which the Company uses as a routine source of working capital funding, is dependent on the level of accounts receivable eligible to be sold and the financial institutions' willingness to purchase such receivables. The total amounts sold in first quarter 2025 and 2024 were $676 million and $698 million, respectively. Based on the original terms of receivables sold for certain programs and actual outstanding balance of receivables under servicing agreements, the Company estimates that $401 million and $385 million of these receivables would have been outstanding as of March 31, 2025 and December 31, 2024, respectively, had they not been sold under these factoring programs.

Eastman works with suppliers to optimize payment terms and conditions on accounts payable to enhance timing of working

capital and cash flows. The Company has a voluntary supplier finance program to provide suppliers with the opportunity to sell receivables due from Eastman to a participating financial institution. For additional information, see Note 1, "Significant Accounting Policies", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

Debt and Other Commitments

At March 31, 2025, the Company's borrowings totaled $5.0 billion with various maturities. In first quarter 2025, the Company issued an additional $250 million aggregate principal amount of the 5.0% notes due August 2029 in a registered public offering (the "2029 Notes"), which was originally issued in August 2024, resulting in an aggregate principal amount of $750 million. The net proceeds from first quarter 2025 issuance was $246 million. The Company also repaid the $450 million 3.80% notes due March 2025. There were no debt extinguishment costs associated with the repayment of this debt.

See Note 4, "Borrowings", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report for additional information.

See "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Other Financial Information - Debt and Other Commitments" in Part II, Item 7 of the Company's 2024 Annual Report on Form 10-K for information on other commitments.

Credit Facility, Term Loans, and Commercial Paper Borrowings

The Company has access to a $1.50 billion revolving credit agreement (the "Credit Facility") that matures in February 2029. Borrowings under the Credit Facility are subject to interest at varying spreads above quoted market rates and a commitment fee is paid on the total unused commitment. The Credit Facility includes sustainability-linked pricing terms, provides available liquidity for general corporate purposes, and supports commercial paper borrowings. At March 31, 2025 and December 31, 2024, the Company had no outstanding borrowings under the Credit Facility. The Company's commercial paper borrowings were $285 million at March 31, 2025 with a weighted interest rate of 4.61%. The Company had no commercial paper borrowings at December 31, 2024.

In first quarter 2025, the Company repaid $100 million of the remaining $250 million five-year term loan (the "2027 Term Loan"). There were no extinguishment costs associated with the partial repayment of the loan. The outstanding balance on the 2027 Term Loan was $150 million at March 31, 2025 and $250 million at December 31, 2024, with variable interest rates of 5.55% and 5.58%, respectively. The 2027 Term Loan is subject to interest at a spread above quoted market rates.

The Credit Facility and the 2027 Term Loan contain customary covenants, including requirements to maintain certain financial ratios, that determine the events of default, amounts available, and terms of borrowings. The Company was in compliance with all applicable covenants at both March 31, 2025 and December 31, 2024. The total amount of available borrowings under the Credit Facility was $1.5 billion as of March 31, 2025.

See Note 4, "Borrowings", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report for additional information.

Net Debt

(Dollars in millions)

March 31, 2025 December 31, 2024
Total borrowings $5,021 $5,017
Less: Cash and cash equivalents 418 837
Net debt (1) $4,603 $4,180

(1) Includes non-cash increase of $21 million in 2025 and non-cash decrease of $32 million in 2024 resulting from foreign currency exchange rates.

Capital Expenditures

Capital expenditures were $147 million and $185 million in first three months 2025 and 2024, respectively. Capital expenditures in first three months 2025 were primarily for the AM segment methanolysis plastic-to-plastic molecular recycling manufacturing facilities, other targeted growth initiatives, and site modernization projects. The Company expects that 2025 capital expenditures will be approximately $550 million, primarily for targeted growth initiatives, including the AM segment methanolysis plastic-to-plastic molecular recycling manufacturing facilities, and site modernization projects.

Stock Repurchases

In December 2021, the Company's Board of Directors authorized the repurchase of up to $2.5 billion of the Company's outstanding common stock at such times, in such amounts, and on such terms, as determined by management to be in the best interest of the Company and its stockholders (the "2021 authorization"). No shares of common stock were repurchased during first quarter 2025. As of March 31, 2025, a total of 11,612,158 shares have been repurchased under the 2021 authorization for $1.1 billion. Both dividends and share repurchases are key strategies employed by the Company to return value to its stockholders.

CRITICAL ACCOUNTING ESTIMATES

In preparing the consolidated financial statements in conformity with GAAP, management must make decisions which impact the reported amounts and the related disclosures. Such decisions include the selection of the appropriate accounting principles to be applied and assumptions on which to base estimates and judgments that affect the reported amounts of assets, liabilities, sales revenue and expenses, fair value of disposal groups, and related disclosure of contingent assets and liabilities. On an ongoing basis, Eastman evaluates its estimates, including those related to impairment of long-lived assets, environmental costs, pension and other postretirement benefits, litigation and contingent liabilities, and income taxes. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Management believes the critical accounting estimates described in Part II, Item 7 of the Company's 2024 Annual Report on Form 10-K are the most important to the fair presentation of the Company's financial condition and results. These estimates require management's most significant judgments in the preparation of the Company's consolidated financial statements.

RECENTLY ISSUED ACCOUNTING STANDARDS

For information regarding the impact of recently issued accounting standards, see Note 1, "Significant Accounting Policies", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

Market risk

As filed, 985 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Eastman has exposure to various market risks principally due to changes in foreign currency exchange rates, the pricing of various commodities, and interest rates. In an effort to manage these risks, the Company employs various strategies, including pricing, inventory management, and hedging. The Company enters into derivative contracts which are governed by policies, procedures, and internal processes set forth by its Board of Directors.

The Company determines its exposures to market risk by utilizing sensitivity analyses, which measure the potential losses in fair value resulting from one or more selected hypothetical changes in foreign currency exchange rates, commodity prices, or interest rates. For more information regarding exposures, refer to Part II, Item 7A of the Company's 2024 Annual Report on Form 10-K.

There have been no material changes to the Company's market risks from those disclosed in Part II, Item 7A of the Company's 2024 Annual Report on Form 10-K.

Controls and procedures

As filed, 2,091 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Disclosure Controls and Procedures

Eastman maintains a set of disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the Company's disclosure controls and procedures. Based on that evaluation, the CEO and CFO have concluded that as of March 31, 2025, the Company's disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed was accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company's internal control over financial reporting that occurred during first quarter 2025 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

Risk factors

As filed, 269 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For information regarding the Company's material known risk factors which could materially adversely affect the Company, its business, financial condition, or results of operations, see "Risk Factors" in Part I, Item 1A of the Company's 2024 Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-01-01 to 2025-03-31$2.29bnus-gaap:Revenues
Cost of revenue3 months2025-01-01 to 2025-03-31$1.72bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2025-01-01 to 2025-03-31$567.0mus-gaap:GrossProfit
Research and development3 months2025-01-01 to 2025-03-31$67.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2025-01-01 to 2025-03-31$182.0mus-gaap:SellingGeneralAndAdministrativeExpense
Income tax3 months2025-01-01 to 2025-03-31$70.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-01-01 to 2025-03-31$182.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-01-01 to 2025-03-31$1.57us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-01-01 to 2025-03-31$1.58us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-01-01 to 2025-03-31116,500,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2025-01-01 to 2025-03-31−$167.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2025-01-01 to 2025-03-31$147.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2025-01-01 to 2025-03-31$96.0mus-gaap:PaymentsOfDividends
Current assetsAt period end2025-03-31$3.90bnus-gaap:AssetsCurrent
Total assetsAt period end2025-03-31$14.97bnus-gaap:Assets
Current liabilitiesAt period end2025-03-31$2.27bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-03-31$9.03bnus-gaap:Liabilities
Long-term debtAt period end2025-03-31$4.74bnus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2025-03-31$285.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2025-03-31$5.87bnus-gaap:StockholdersEquity
Shares outstandingAt period end2025-03-31115,460,148 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000915389-25-000105. Last ingested by Listed: Nov 13, 2026, 15:53 ET. Listed shows no prices and gives no investment advice.